IJCS | Volume 31, Nº4, Julho / Agosto 2018

441 1. KalilFilhoR,HajjarLA,BacalF,HoffPM,DizMdelP,GalasFR,etal;Grupo deEstudosemInsuficiênciaCardíacadaSociedadeBrasileiradeCardiologia (GEIC/SBC);SociedadeBrasileiradeOncologiaClínica;InstitutodoCoração –FaculdadedeMedicinadaUniversidadedeSãoPaulo;InstitutodoCâncer do Estado de São Paulo – Faculdade de Medicina da Universidade de São Paulo. [I Brazilian guideline for cardio-oncology from Sociedade Brasileira de Cardiologia]. Arq Bras Cardiol. 2011;96(2 Suppl.1):1-52. 2. Lis CG, RodeghierM, Grutsch JF, GuptaD. Distribution and determinants of patient satisfaction in oncology with a focus on heath related quality of life. BMC Heath Serv Res. 2009 Oct 21;9:190. 3. Mota DD, Cruz DA, Pimenta CA. Fadiga: uma análise de conceito. Acta Paul Enferm. 2005;18(3):285-93. 4. Evans WJ, Lambert CP. Physiological basis of fatigue. Am J Phys Med Rehabil. 2007;86(1 Suppl):S29-46. 5. Cella D, Davis K, Breitbart W, Curt G; Fatigue Coalition. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol. 2001;19(14):3385-91. 6. Gutstein HB. The biologic basis of fatigue. Cancer. 2000; 92(6 Suppl):1678-83. 7. Mettauer B, Zoll J, Sandchez H, Lampert E, Ribera F, Veksler V, et al. Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects J AmColl Cardiol. 2001;38(4):947-54. 8. Alpert CM, Smith MA, Hummel SL, Hummel EK. Symptom burden in heart failure: assement, impact on outcomes, and management. Heart Fail Rev. 2017;22(1):25-39. 9. Brannstrom S, Boman K. Effects of person-central and integrated chronic heart failure and palliative home care. PREFER: a randomized controlled study. Eur J Heart Fail. 2014;16(10):1142-51. 10. Markowitz AJ, RabowMW. Palliative management of fatigue at the close of life: "it feels like my body is just worn out". JAMA 2007;298(2):217. 11. Barsevick AM, Whitmer K, Walker L. In their own words: using the common sense model to analyze patient descriptions of cancer-related fatigue. Oncol Nurs. 2001;28(9):1363-9. 12. Zwarts MJ, Bleijenberg G, van Engelen BG. Clinical neurophysiology of fatigue. Clin Neurophysiol. 2008;119(1):2-10. 13. Barry BK, Enoka RM. The neurobiology of muscle fatigue: 15 years later. Integr Comp Biol. 2007;47(4):465-73. 14. Saibene F, Minetti AE. Biomechanical and physiological aspects of legged locomotion in humans. Eur J Appl Physiol. 2003;88(4-5):297-316. 15. Powers SK, Howley ET. Fisiologia do exercício. In: Músculo esquelético; estrutura e função. São Paulo: Manole; 2014. 16. Davis MP, Walsh D. Mechanisms of fatigue. J Support Oncol. 2010;8(4):164-74. 17. Ascensão A, Magalhães J, Oliveira J, Duarte J, Soares J. Fisiologia da fadiga muscular. Delimitação conceptual, modelos de estudo e mecanismos de fadiga de origem central e periférica. Revista Portuguesa de Ciências do Desporto. 2003;3(1):108-23. 18. Mckenna MJ, Medved I, Goodman CA, Brown MJ, Bjorksten AR, Murphy KT, et al. N-acetycysteine attenuates the decline inmuscle Na+, K+- pump activity and and delays fatigue during prolonged exercise in humans. J Physiol. 2006;576(Pt 1):279-88. 19. Maughan D, Toth M. Discerning primary and secundary factors responsible for clinical fatigue in multisystem diseases. Biology (Basel). 2014;3(3):606-22. 20. Zambroski CH, Moser DK, Bhat G, Ziegler C. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs. 2005;4(3):198-206. 21. Doehmer W, Frenneaux M, Anker SD. Metabolic impairment in heart failure: the myocardic and systemic perspective. J Am Coll Cardiol. 2014;64(13):1388-400. 22. Vescovo G, Dalla Libera L, Serafin F, Leprotti C, Facchin L, Volterrani M, et al. Improved exercise tolerance after Losartan and Enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition. Circulation. 1998;98(17):1742-9. 23. Dall’ Ago P, Stein R, Ribeiro JP. Exercício empacientes com Insuficiência Cardíaca: do dogma às evidências. Revista da Sociedade de Cardiologia do Rio Grande do Sul. 2005;13(4):1-5. 24. MillerMS, VanBuren P, LeWinterMM, Braddock JM, Ades PA, Maughan DW, et al. Chronic heart failure decreases cross-bridge kinetics in single skeletal muscle fibres from humans. J Physiol. 2010;588(Pt 20):4039-53. 25. Rehn TA, Munkvik, M, Lunde PK, Sjaastad L, Sejersted OM. Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease- specific myopathy or a result of deconditioning? Heart Fail Rev. 2012;17(3):421-36. 26. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton SymptomAssssment System (ESAS): a simplemethod for the assessment of palliative care patients. J Palliat Care.1991;7(2):6-9. 27. Ezekowitz JA, Thai V, Hodnefield TS, Sanderson L, Cujec B. The correlation of standard heart failure assessment and palliative care questionnaries in a multidisciplinary heart failure clinic. J Pain Symptom Manage. 2011;42(3):379-87. 28. Servaes P, Verhagen S, Schreuder HW, Veth RP, Bleijenberg G. Fatigue after treatment for malignant and benign bone and soft tissue tumors. J Pain Symptom Manage. 2003;26(6):1113-22. 29. Roberts BM, Ahn B, Smuder AJ, Al-Rajhi M, Gill LC, Beharry AW, et al. Diaphragm and ventilatory dysfunction during cancer cachexia. FASEB J. 2013;27(7):2600-10. 30. Lee JQ, Simmonds MJ, Wang XS, Novy DM. Difference in physical performance between men and women with and without lymphoma. Arch Phys Med Rehabil 2003;84(12):1747-52. 31. Bower JE, Ganz PA, TaoML, HuW, Belin TR, Sepah S, et al. Inflammation biomarkers and fatigue during radiation therapy for breast cancer and prostate cancer. Clin Cancer Res. 2009;15(17):5534-40. 32. Doehner W, von Haehling S, Anker SD, Lainscak M. Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review. Wien Klin Wochenschr. 2009;121(9-10):293-6. 33. Fink MA, Sullivan SL, Zerwic JJ, Piano MR. Fatigue with systolic heart failure. J Cardiovasc Nurs. 2009;24(5):410-7. 34. Escalante CP, Kallen MA, Valdres RU, Morrow PK, Manzullo EF. Outcomes of a cancer-related fatigue clinic in a comprehensive cancer centre. J Pain Simptom Manage. 2010;39(4):691-701. 35. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. May 28, 2009. (4.03: June 14, 2010). Bethesda: U.S. Department of Health and Human Services; National Institutes of Health; National Cancer Institute. 36. Dimeo F, Schwartz S, Wesel N, Voigt A, Thiel E. Effects of an endurance and resistance exercice program on persistent cancer-fatigue after treatment. Ann Oncol. 2008;19(8):1495-9. 37. Schwartz AL, Mori M, Gao R, Nail LM, King ME. Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med Sci Sports Exerc. 2001;33(5):718-23. 38. Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD008465. 39. Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, andmanagement. J AmColl Cardiol. 2009;53(24):2231-47. 40. Adão R, de Keulenaer G, Leite-Moreira A, Brás-Silva C. Cardiotoxicity associated with cancer therapy: pathophysiology and prevention strategies. Rev Port Cardiol. 2013;32(5):395-409. Referências Borges et al. Cardio-oncologia e sintoma fadiga Int J Cardiovasc Sci. 2018;31(4)433-442 Artigo de Revisão